GlassScriptPhysician profile
Charles Christopher Nicholas
NPI 1124083100
$6,908.47
in general payments reported to CMS, 2019-2025
38 companies · $1,120 in 2025
The $1,120 reported for 2025 was more than what 82% of Podiatrist providers received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $703 · 2020: $270 · 2021: $772 · 2022: $1,026 · 2023: $1,698 · 2024: $1,319 · 2025: $1,120.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,137.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,137.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $2,078.92 | 2019-2025 | Citrefix, Viaflow, Prostep |
| Horizon Therapeutics Plc | $609.72 | 2022-2023 | Krystexxa |
| Bioventus LLC | $576.04 | 2019-2025 | Exogen Ultrasound Bone Healing System, Stimrouter Implantable Kit, Stimrouter Implantable Kit |
| Kerecis Limited | $574.14 | 2019-2025 | Kerecis Omega3 Marigen, Kerecis Surgiclose, Kerecis Omega3 Surgiclose |
| Smith+Nephew, INC. | $379.12 | 2019-2025 | Grafix Pl, Stravix |
| Convatec INC. | $344.95 | 2019-2025 | |
| Medtronic, INC. | $338.04 | 2025 | Inceptiv, Venaseal, Intellis Adaptivestim |
| Tactile Systems Technology INC | $269.75 | 2019-2022 | |
| Misonix INC | $149.05 | 2019 | |
| Bolton Medical INC | $142.87 | 2024 | Treo Abdominal Stent-Graft System |
| Janssen Pharmaceuticals, INC | $120.98 | 2023 | Xarelto |
| Lifenet Health | $113.32 | 2023-2025 | Theragenesis Wound Matrix |
| Heron Therapeutics, INC. | $111.45 | 2021-2022 | |
| Fortis Surgical, LLC | $101.33 | 2023 | |
| Paratek Pharmaceuticals, INC. | $94.43 | 2021-2025 | Nuzyra |
Show all 38 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $93.62 | 2019-2025 | Puraply Wound Matrix |
| Ossio INC | $84.74 | 2022 | |
| In2bones USA, LLC | $71.43 | 2021 | |
| Alfasigma USA, INC. | $66.73 | 2020-2022 | |
| Averitas Pharma INC. | $66.33 | 2024-2025 | Qutenza |
| Abbott Laboratories | $61.26 | 2021-2024 | Proclaim |
| Innovation Technologies INC | $56.13 | 2024 | Irrisept |
| Amgen INC. | $50.65 | 2024 | Krystexxa |
| Kowa Pharmaceuticals America, INC. | $44.17 | 2022-2023 | Seglentis |
| Next Science LLC | $42.23 | 2023 | Surgx, Xperience, Blastx |
| Merck Sharp & Dohme LLC | $32.65 | 2019 | |
| Normatec Industries, LP | $27.06 | 2019 | |
| Grt US Holding, INC. | $25.01 | 2022 | |
| Integra Lifesciences Corporation | $24.30 | 2021 | |
| Nevro Corp. | $24.15 | 2022 | |
| Nabriva Therapeutics, Plc | $22.93 | 2021 | |
| Abbvie INC. | $21.51 | 2022 | |
| Wright Medical Technology, INC. | $20.10 | 2020 | |
| Sanara Medtech INC. | $19.28 | 2025 | Celleraterx |
| Allergan, INC. | $17.08 | 2019 | |
| Cashflow Solutions, LLC | $14.67 | 2023 | Lympha Press Optimal Plus(US) Bt, Pcd-52 737a (US) White, Pcd-51 731a (US) - White |
| Depuy Synthes Sales INC. | $13.74 | 2023 | Na |
| Dynasplint Systems INC. | $4.59 | 2023 | Dynasplint |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Charles Nicholas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.